Edible mushrooms as potential functional foods in amelioration of hypertension

Edible mushrooms are popular functional foods attributed to their rich nutritional bioactive constituent profile influencing cardiovascular function. Edible mushrooms are omnipresent in various prescribed Dietary Approaches to Stop Hypertension, Mediterranean diet, and fortified meal plans as they are rich in amino acids, dietary fiber, proteins, sterols, vitamins, and minerals. However, without an understanding of the influence of mushroom bioactive constituents, mechanism of action on heart and allergenicity, it is difficult to fully comprehend the role of mushrooms as dietary interventions in alleviating hypertension and other cardiovascular malfunctions. To accomplish this endeavor, we chose to review edible mushrooms and their bioactive constituents in ameliorating hypertension. Hypertension and cardiovascular diseases are interrelated and if the former is managed by dietary changes, it is postulated that overall heart health could also be improved. With a concise note on different edible varieties of mushrooms, a particular focus is presented on the antihypertensive potential of mushroom bioactive constituents, mode of action, absorption kinetics and bioavailability. Ergosterol, lovastatin, cordycepin, tocopherols, chitosan, ergothioneine, gamma-aminobutyric acid, quercetin, and eritadenine are described as essential bioactives with hypotensive effects. Finally, safety concerns on allergens and limitations of consuming edible mushrooms with special reference to chemical toxins and their postulated metabolites are highlighted. It is opined that the present review will redirect toxicologists to further investigate mushroom bioactives and allergens, thereby influencing dietary interventions for heart health.

Automated summary

Edible mushrooms are popular functional foods due to their rich nutritional bioactive constituents that influence cardiovascular function. They are commonly included in dietary interventions for hypertension and other cardiovascular malfunctions as they contain amino acids, dietary fiber, proteins, sterols, vitamins, and minerals. This review focuses on the antihypertensive potential of mushroom bioactive constituents, their mode of action, absorption kinetics, and bioavailability. Essential bioactives such as ergosterol, lovastatin, cordycepin, tocopherols, chitosan, ergothioneine, gamma-aminobutyric acid, quercetin, and eritadenine are described as having hypotensive effects. Safety concerns regarding allergens and limitations of consuming edible mushrooms, including chemical toxins and their metabolites, are highlighted.